White, Wendy
Article History
Received: 22 May 2019
Revised: 11 October 2019
Accepted: 28 October 2019
First Online: 13 November 2019
Compliance with ethical standards
:
: Wendy White has received compensation as a consultant and employee of Vitrisa Therapeutics. She is also a member of TREND community advisory board. She owns small amounts (<1%) of stock in Amicus Therapeutics, Rocket Therapeutics, Abeona Therapeutics, Sangamo Therapeutics, CRISPR Therapeutics. She is currently chair of the board of Global Genes and was previously director-at-large of National Organization for Rare Disorders (NORD). She is also the parent of a child with a rare connective tissue disorder with no available therapy.